crisis meeting?

good news...awesome


but date ?? 2011

= Posted Sep. 22, 2011 at 12:01 AM Updated Sep 22, 2011 at 10:03 PM








- See more at:

http://www.tauntongazette.com/article/20110922/News/309229204#sthash.rda4yzpv.dpuf

http://m.theglobeandmail.com/report-on-business/ottawa-rejects-marijuana-firm-cen-biotechs-licence-application/article23002460/?service=mobile

Still 3 mill dollar traded.....WOW

Friday's power hour was just amazing... There must be something IMO

More Then 3 million dollars traded the last 3 trading days!!!.... Yeah unbelievable.

So it sais

$FITX Article

http://www.mmj.today/cen-biotech-shows-strong-uptrend/



Last week, following some very positive news about the direction that Creative Edge Nutrition (ticker Symbol FITX) is taking from new CEO James Robinson, the company gained more then 100% in its stock price. There was also mention of an updated website that will make it’s appearance this week.

From a fundamental stand point, the company is extremely under valued, with a lot more potential for serious gains. From a technical standpoint, the stock is significantly over sold, with price movement that has climbed up and broke through the 20 and 50 day SMA and EMA lines. This is a very positive indicator of continued upward momentum.

In a desperate attempt to offset this positive energy, the detractors have employed another despicable ploy to confuse inexperienced investors.

Yesterday we saw several headlines from news outlets implying that Health Canada has rejected the application of Cen Biotech to grow medical marijuana. In a quick perusal of these stories, it becomes blatantly obvious that these headlines are misleading,
The articles all claim the same source, Stephane Shank, a representative of Health Canada, and a statement supposedly made to the Globe and Mail. This statement indicates that Health Canada intends to reject the application, if CEN Biotech does not respond to the rejection letter within 20 days. This means they have not rejected the application, as of yet, and the implication that they have, is irresponsible journalism.

If this letter were to actually exist, there is no doubt that the company would respond well within the allotted time. However if this letter were to actually exist, a communication about it to an outside media source would be in clear violation of Health Canada’s policy. And why bring it to the attention of a reporter that has been proven to have an agenda against the company?

Many investors have tried to make contact with this individual, but at this time there has been no response. One interesting statement that seems to have come out, includes a paragraph copied from an article that was published on June second of last year in the International Business Times. This article does not make any reference to Cen Biotech.

Considering the article perpetrating the myth of this particular document, is written by an individual who has repeatedly insulted the intelligence of his readers with misleading and inaccurate information, We must look for other sources for correct information.

At this time there have been no formal statements from Health Canada, or from Cen Biotech, to validate the existence of such a letter. Until such a statement surfaces, it would be a prudent course of action to consider such a letter non-existent.
The most recent statement that can be found about the company is a ” Notification of late filing” filed on February 14, 2015, indicating that the quarterly report will be filed on February 19, 2015. The most interesting statement in this document is the reason why the extension is needed. “Working with PCAOB auditor regarding financials for CEN Biotech, Inc. spin out from Creative Edge Nutrition, Inc.” This can only be taken as a very positive statement as to the progress of the much anticipated spin off.

At this point, an investor in Cen Biotech is well aware of the small cast of characters that seem bent on manipulating the share price through misinformation. Due to so much positive new information that’s come to light, the detractors are running scared, they are growing desperate, bringing in the bench warmers, throwing in the towel, and making a final last ditch attempt to confuse less savvy shareholders into making the mistake of selling valuable shares.

It is clear that due to the strong positive attitudes and insights of a very knowledgeable group of investors, who have worked diligently to stay informed about all aspects of the company, that there is far more potential to gain profit by following the example of investors who actually know what they are doing.

Cen Biotech is a solid company, with a fantastic management, a well diversified spectrum of projects, and many indicators that success is imminent.


$FITX

Bill needs to react by tuesday!

Grant Robertson Sensationalism – A Globe and Mail Commentary

http://www.basher.wiki/grant-robertson-sensationalism-a-globe-and-mail-commentary-part-3/

Once again, it seems that I’ve been asked to write another rebuttal to a piece written by Grant Robertson which this time presents itself with some damning “claims”. This analysis of the most recent submission, published by the Globe & Mail, written by author Grant Robertson on February 14th, 2015 will be short and sweet since Mr. Grant Robertson has clearly demonstrated that no sources or means for checking facts are necessary within his articles. I bring to you another commentary on the professional writings of Grant Robertson; please take a look.


This article once again falls under the category of a number of pieces (Totaling ELEVEN now) that serve the purpose of damning the actions and practices of CEN Biotech while also critically smearing the capacity of various institutions to perform their legal duties. Grant Robertson has questioned the actions and performance of Health Canada, the Minister of Health, the SEC, the RCMP, those in charge of sorting through files for MMPR applicants and he has, in the process, insulted those who have gathered evidence (both positive and negative) about the company for the past year. The quotes which Grant uses in his articles are not always directly related to the questions he raises, but yet he gives his opinions to deflect the material in order to make inferences related to the questions he raises. The thoughts expressed in this commentary are my own and where possible I will try to make reference to supportive text. Please conduct your own due diligence before making any sort of investment decision.

.
.
. etc

$FITX

Disclaimer: Globe and mail's web sight.


The information on this site is for information purposes only. The Globe and Mail Inc. (the "Globe", its affiliates and content licensors assume no liability for any inaccurate, delayed or incomplete information, nor for any actions taken in reliance thereon. The information contained about each individual and firm has been supplied by such individual or firm without verification by us. Certain links on this Globe site may take you to other websites. The Globe provides these links only as a convenience and not as an endorsement by the Globe. These linked sites are not under the control of the Globe. If you decide to visit any linked site, you do so at your own risk and it is your responsibility to take all protective measures to guard against viruses and other destructive elements. The Globe is not responsible for the content of any such linked sites or any other web page that is not part of this Globe site. Unless otherwise expressly provided, the Globe makes no representation or warranty regarding, and does not endorse, any linked site or the information, products or services appearing thereon. Accordingly, you agree that the Globe will not be responsible or liable in any way for the accuracy, relevancy, copyright compliance, legality, or decency of material contained in any site linked from this Globe site.

LOL...only the GlobeandMail recieved da News....No other News Channel!?

...and then there's stated:

Looking forward to the coming weeks/months.

That's way too funny!

About 'being funny': Next week we'll meet da MA(200).
Now it's going to be fun indeed next week.





All have a safe weekend. You too


GO $FITX

HAHAHAAA...old publication re-updated 02/14/2015.

Is Lakeshore gonna lose another 2Mill $ or more in a another lawsuit againt them ?

Think about it....What's the deal with Lakeshore/OMB?...wink wink


$FITX

It was just a matter of time

Mister Bus Driver..."Move that bus!"



GO $FITX

Good post, this has always been a moneymaker.

Most likely... Looking forward to tomorrow. Another 100 mill volume?

$FITX

$FITX +40%

$FITX + 40%

PR tomorrow?

Lovely Volume $ ... and it hasn't started yet...sssht

Make them Pay +46%%%%%%%%%%%%%%%%

LOL

*** Video Chart FITX: ***

$FITX ~

$FITX ~

Thank you.


$FITX

A Dollar = A Dollar

Go FITX


All Good Luck

"From current levels FITX is a stock to watch and deserves to be at the top of speculators watched lists. This one has a history of big moves and already has a loyal following of investors who have shown the can take FITX to the top most traded stock on the entire bb exchange."

$$$$$ TO BE MADE ... YES YOU CAN

$FITX + 50% Two weeks time $$$$$$$$$

To da Mooooooooooon ...lol

Trade it ass you wish...



""Creative Edge Nutrition, Inc. Announces Intention to Spin Off Canadian Wholly-Owned Subsidiary, CEN Biotech Inc.

http://www.marketwired.com/press-release/creative-edge-nutrition-inc-announces-intention-spin-off-canadian-wholly-owned-subsidiary-pinksheets-fitx-1970123.htm

MADISON HEIGHTS, MI--(Marketwired - Nov 19, 2014) - Creative Edge Nutrition, Inc. (PINKSHEETS: FITX), a nutritional supplement company focusing on active lifestyles, today announced that its Board of Directors has approved a plan to spin off CEN Biotech Inc., its Canadian wholly-owned subsidiary, to its shareholders. The parties expect the transaction to take place in the near future.

CEN Biotech Inc. intends to be an independent, publicly-traded company, which will be audited by a registered public accounting firm and fully reporting. It will be led by Mr. Bill Chaaban as Chairman, President and Chief Executive Officer.

All current officers and directors of CEN Biotech Inc. will immediately resign from Creative Edge Nutrition, as Creative focuses its plans and operations on Nutrition under its new Chief Executive Officer, Mr. James Robinson, a noted entrepreneur in the dietary nutrition space.

The decision to spin off CEN Biotech Inc. gives each company, Creative Edge Nutrition and CEN Biotech, the ability to concentrate their respective resources and efforts in their own individual area of specialty. The markets and technologies of each area of specialty are very different. CEN Biotech Inc. will devote its efforts and resources to advance in the area of specialty pharmaceuticals, and Creative Edge Nutrition will devote its efforts and resources on nutrition products.

Upon completion of the spin-off, all shareholders of Creative Edge Nutrition, Inc. will retain their shares in Creative Edge Nutrition while additionally getting shares in CEN Biotech Inc., which will be a new publicly-traded company. The distribution of CEN Biotech Inc. shares will be on a pro rata basis to the Creative Edge Nutrition shareholders based on the number of shares of Creative Edge Nutrition shares owned by each shareholder.

"This is a unique opportunity to combine the legacy, scale and scope of a well-established business while capturing the entrepreneurial energy of a new company to better serve the needs of each." stated CEO Bill Chaaban. "By eliminating the potential conflicts that currently exist between the dynamics created by both sectors, each business will now be positioned for significant vertically integrated growth."

CEN Biotech Inc. plans include working and consulting with leading experts in the field. Chaaban continued, "After a year of discussion with key figures in capital markets, it became apparent that a standalone medical marijuana company was needed. We believe that the new format will better position both companies to capitalize on favorable industry trends, better serve their customers and enhance their growth prospects by operating independently."

The Transfer agent should not be contacted as they have no information to give out regarding the transaction. There can be no assurance that the spinout will ultimately be consummated or of the ultimate timing, including obtaining a trading symbol and Depository Trust Company approval for CEN Biotech Inc., if it is completed. ""

Thank you Brentpdc.

Be ready for another + 10% tomorrow

There we go

$FITX